Sponsor

Glaxo Wellcome

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Glaxo Wellcome appears in 119 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials119
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral TherapyNCT00008554 · lead sponsor · 2000-11-01
UNKNOWN
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsNCT00009061 · lead sponsor · 2000-11-01
UNKNOWN
A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive PatientsNCT00005764 · lead sponsor · 2000-05-01
COMPLETED
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsNCT00004585 · lead sponsor · 1999-10-01
COMPLETED
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsNCT00004852 · lead sponsor · 1999-09-01
COMPLETED
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsNCT00005106 · lead sponsor · 1999-09-01
COMPLETED
Safety and Effectiveness of a Combination Anti-HIV Drug TreatmentNCT00005018 · lead sponsor · 1999-07-01
COMPLETED
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsNCT00005663 · lead sponsor · 1999-06-01
UNKNOWN
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV DrugsNCT00002442 · lead sponsor · 1999-06-01
COMPLETED
A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected PatientsNCT00002245 · lead sponsor · 1999-04-01
COMPLETED
A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirNCT00002423 · lead sponsor · 1999-03-01
COMPLETED
The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsNCT00002404 · lead sponsor
COMPLETED
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastNCT00002320 · lead sponsor
COMPLETED
An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2NCT00002023 · lead sponsor
COMPLETED
The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemNCT00002288 · lead sponsor
COMPLETED
A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXNCT00002340 · lead sponsor
COMPLETED
Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARCNCT00002020 · lead sponsor
COMPLETED
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)NCT00002014 · lead sponsor
COMPLETED
An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral PentamidineNCT00001990 · lead sponsor
COMPLETED
The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease InhibitorsNCT00002213 · lead sponsor
COMPLETED
A Study of Amprenavir in Patients With Protease Inhibitor-Related ComplicationsNCT00002417 · lead sponsor
COMPLETED
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected PatientsNCT00002195 · lead sponsor
COMPLETED
A Study of 1592U89 in HIV-Infected AdultsNCT00002200 · lead sponsor
COMPLETED
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)NCT00002026 · lead sponsor
COMPLETED
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZTNCT00002436 · lead sponsor
COMPLETED
A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARCNCT00002046 · lead sponsor
COMPLETED
3TC (Lamivudine; GR109714X) Open-Label ProgramNCT00002108 · lead sponsor
COMPLETED
A Study of 141W94 in Combination With Other Anti-HIV DrugsNCT00002372 · lead sponsor
COMPLETED
A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV TreatmentNCT00002216 · lead sponsor
COMPLETED
A Study of 1592U89 and Ethanol When Given Together to HIV-Infected PatientsNCT00002198 · lead sponsor
COMPLETED
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsNCT00002084 · lead sponsor
COMPLETED
The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected PatientsNCT00002373 · lead sponsor
COMPLETED
A Study of a Combination of Four Drugs in Patients With Recent HIV InfectionNCT00002233 · lead sponsor
COMPLETED
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)NCT00004981 · lead sponsor
UNKNOWN
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsNCT00002391 · lead sponsor
COMPLETED
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia ComplexNCT00002163 · lead sponsor
COMPLETED
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus DiseaseNCT00002001 · lead sponsor
COMPLETED
A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV InfectionNCT00002086 · lead sponsor
COMPLETED
A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSNCT00002285 · lead sponsor
COMPLETED
A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineNCT00001994 · lead sponsor
COMPLETED
The Safety and Effectiveness of 524W91NCT00002335 · lead sponsor
COMPLETED
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular DiseasesNCT00002044 · lead sponsor
COMPLETED
A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantNCT00002284 · lead sponsor
COMPLETED
A Study of 1592U89 in HIV-Infected ChildrenNCT00002197 · lead sponsor
COMPLETED
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)NCT00002048 · lead sponsor
COMPLETED
A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients With Weakened Immune SystemsNCT00002315 · lead sponsor
COMPLETED
A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002440 · lead sponsor
COMPLETED
Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)NCT00002063 · lead sponsor
COMPLETED
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.NCT00002199 · lead sponsor
COMPLETED
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii PneumoniaNCT00001991 · lead sponsor
COMPLETED
A Study of Amprenavir in HIV-Infected PatientsNCT00002405 · lead sponsor
COMPLETED
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002389 · lead sponsor
COMPLETED
A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV DrugsNCT00002217 · lead sponsor
COMPLETED
A Prospective Double-Blind Study of Retrovir in Early HIV InfectionNCT00002045 · lead sponsor
COMPLETED
The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionNCT00002290 · lead sponsor
COMPLETED
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received TreatmentNCT00005017 · lead sponsor
UNKNOWN
A Study of 1592U89 in HIV-Infected PatientsNCT00002388 · lead sponsor
COMPLETED
The Safety and Effectiveness of 935U83 in HIV-Infected PatientsNCT00002338 · lead sponsor
COMPLETED
A Study of Two Anti-HIV Drug CombinationsNCT00002203 · lead sponsor
COMPLETED
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment RegimenNCT00002205 · lead sponsor
COMPLETED

Drugs studied in this sponsor's trials

40 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Glaxo Wellcome as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
zidovudine59
abacavir sulfate30
lamivudine21
amprenavir18
didanosine18
lamivudine / zidovudine10
nelfinavir mesylate9
zalcitabine9
zidovudine RxCUI 11413 · Lead sponsor in 26 linked trial(s) · 0 currently recruiting 59 trials abacavir sulfate RxCUI 221052 · Lead sponsor in 28 linked trial(s) · 0 currently recruiting 30 trials lamivudine RxCUI 68244 · Lead sponsor in 18 linked trial(s) · 0 currently recruiting 21 trials amprenavir RxCUI 228656 · Lead sponsor in 16 linked trial(s) · 0 currently recruiting 18 trials didanosine RxCUI 3364 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 18 trials lamivudine / zidovudine RxCUI 214671 · Lead sponsor in 9 linked trial(s) · 0 currently recruiting 10 trials nelfinavir mesylate RxCUI 266565 · Lead sponsor in 8 linked trial(s) · 0 currently recruiting 9 trials zalcitabine RxCUI 3363 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 9 trials acyclovir RxCUI 281 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 7 trials atovaquone RxCUI 60212 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 7 trials efavirenz RxCUI 195085 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 7 trials indinavir sulfate RxCUI 203153 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 7 trials valacyclovir hydrochloride RxCUI 236081 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 6 trials sulfamethoxazole / trimethoprim RxCUI 10831 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 5 trials stavudine RxCUI 59763 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials nevirapine RxCUI 53654 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials ritonavir RxCUI 85762 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials adefovir dipivoxil RxCUI 141400 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials clindamycin RxCUI 2582 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials interferon alfa-2a RxCUI 5879 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials leucovorin calcium RxCUI 225852 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials pentamidine isethionate RxCUI 7995 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials pyrimethamine RxCUI 9010 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials saquinavir RxCUI 83395 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials

Sponsor roles

lead sponsor72
collaborator47
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.